Wilmington Savings Fund Society’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.47M Sell
185,530
-8,535
-4% -$223K 0.1% 157
2026
Q1
$5.45M Sell
194,065
-14,315
-7% -$381K 0.13% 129
2025
Q4
$5.19M Sell
208,380
-7,348
-3% -$185K 0.12% 134
2025
Q3
$5.5M Sell
215,728
-75,143
-26% -$1.85M 0.13% 132
2025
Q2
$7.05M Sell
290,871
-14,800
-5% -$345K 0.13% 136
2025
Q1
$7.75M Sell
305,671
-6,102
-2% -$160K 0.14% 129
2024
Q4
$8.27M Sell
311,773
-11,243
-3% -$305K 0.15% 120
2024
Q3
$9.35M Buy
323,016
+164,032
+103% +$4.79M 0.17% 113
2024
Q2
$4.45M Sell
158,984
-6,068
-4% -$167K 0.17% 115
2024
Q1
$4.58M Buy
+165,052
New +$4.58M 0.18% 117
2023
Q3
$5.71M Sell
172,055
-1,563
-0.9% -$55.3K 0.25% 99
2023
Q2
$6.37M Sell
173,618
-311
-0.2% -$12.1K 0.27% 96
2023
Q1
$7.1M Sell
173,929
-12,706
-7% -$549K 0.31% 86
2022
Q4
$9.56M Sell
186,635
-2,651
-1% -$127K 0.43% 63
2022
Q3
$8.28M Buy
189,286
+476
+0.3% +$23.1K 0.4% 61
2022
Q2
$9.9M Sell
188,810
-7,140
-4% -$364K 0.46% 57
2022
Q1
$10.1M Sell
195,950
-11,476
-6% -$595K 0.4% 68
2021
Q4
$12.2M Sell
207,426
-3,049
-1% -$151K 0.44% 61
2021
Q3
$9.05M Sell
210,475
-591
-0.3% -$26.2K 0.35% 77
2021
Q2
$8.27M Buy
211,066
+1,669
+0.8% +$64.9K 0.32% 80
2021
Q1
$7.59M Sell
209,397
-3,305
-2% -$117K 0.3% 90
2020
Q4
$7.83M Sell
212,702
-6,946
-3% -$255K 0.33% 81
2020
Q3
$7.65M Sell
219,648
-4,059
-2% -$142K 0.35% 77
2020
Q2
$6.94M Sell
223,707
-8,243
-4% -$280K 0.34% 79
2020
Q1
$7.18M Buy
231,950
+1,425
+0.6% +$48.6K 0.42% 73
2019
Q4
$8.57M Sell
230,525
-1,012
-0.4% -$36K 0.43% 79
2019
Q3
$7.89M Sell
231,537
-762
-0.3% -$27.7K 0.43% 83
2019
Q2
$9.55M Sell
232,299
-22,940
-9% -$911K 0.52% 69
2019
Q1
$10.3M Sell
255,239
-2,212
-0.9% -$88.6K 0.56% 60
2018
Q4
$10.7M Sell
257,451
-2,921
-1% -$121K 0.65% 49
2018
Q3
$10.9M Sell
260,372
-144
-0.1% -$5.54K 0.57% 55
2018
Q2
$8.97M Sell
260,516
-5,586
-2% -$191K 0.5% 66
2018
Q1
$8.96M Sell
266,102
-8,958
-3% -$308K 0.51% 66
2017
Q4
$9.45M Sell
275,060
-17,026
-6% -$581K 0.52% 62
2017
Q3
$9.89M Sell
292,086
-17,553
-6% -$564K 0.57% 56
2017
Q2
$9.87M Sell
309,639
-16,050
-5% -$506K 0.59% 51
2017
Q1
$10.6M Sell
325,689
-8,809
-3% -$278K 0.64% 46
2016
Q4
$10.3M Sell
334,498
-955
-0.3% -$29.2K 0.65% 45
2016
Q3
$10.8M Sell
335,453
-3,353
-1% -$112K 0.68% 45
2016
Q2
$11.3M Sell
338,806
-2,848
-0.8% -$90.9K 0.72% 40
2016
Q1
$9.61M Sell
341,654
-2,607
-0.8% -$74.5K 0.62% 46
2015
Q4
$10.5M Sell
344,261
-12,854
-4% -$404K 0.66% 46
2015
Q3
$10.6M Sell
357,115
-201,649
-36% -$6.47M 0.68% 44
2015
Q2
$17.8M Sell
558,764
-4,748
-0.8% -$155K 1.03% 25
2015
Q1
$18.6M Sell
563,512
-8,464
-1% -$269K 1.06% 22
2014
Q4
$16.9M Buy
571,976
+13,123
+2% +$376K 0.95% 29
2014
Q3
$15.7M Sell
558,853
-9,568
-2% -$269K 0.89% 30
2014
Q2
$16M Sell
568,421
-21,453
-4% -$612K 0.88% 31
2014
Q1
$18M Sell
589,874
-14,358
-2% -$428K 1.01% 26
2013
Q4
$17.6M Buy
604,232
+16,131
+3% +$469K 0.99% 27
2013
Q3
$16M Buy
588,101
+11,882
+2% +$323K 0.99% 25
2013
Q2
$15.3M Buy
+576,219
New +$15.9M 0.99% 26

Other funds holding PFE

Wilmington Savings Fund Society's PFE Position: Q2 2026 in Review

Wilmington Savings Fund Society reduced its Pfizer (PFE) stake by 4.4% in Q2 2026, selling an estimated $223K and leaving 185,530 shares worth $4.47M. The position accounts for 0.1% of the portfolio, ranked #157.

Wilmington Savings Fund Society first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $18.6M in Q1 2015. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Wilmington Savings Fund Society held 185,530 shares of Pfizer worth $4.47M as of Q2 2026.
  • Wilmington Savings Fund Society sold 8,535 Pfizer shares in Q2 2026, an estimated $223K.
  • Pfizer made up 0.1% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #157 holding.
  • Wilmington Savings Fund Society first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • Wilmington Savings Fund Society's Pfizer position peaked at $18.6M in Q1 2015.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.